The study proves that improving prehospital systems, not just hospital technology, is the decisive variable in saving lives from STEMI—a lesson with global resonance for health systems facing resource constraints.
A landmark study published in Heart reveals that Chinese scientists have developed and validated an integrated care model that dramatically improves outcomes for patients with ST-segment elevation myocardial infarction (STEMI). The prospective, multicentre, non-randomised controlled trial, conducted across eight tertiary hospitals in China from 2015 to 2019, enrolled 6,817 patients and offers powerful evidence that system-level coordination can overcome resource limitations.
The intervention focused on what happens before a patient reaches the catheterisation lab: regular community public education, skills training for hospitals without percutaneous coronary intervention (PCI) capability, improved referral systems, and an optimised “green channel” for PCI-capable centres. The results were striking. In the intervention group, the rate of symptom-to-reperfusion within 12 hours rose from 65.3% to 91.4%, while symptom-to-admission within 12 hours climbed from 74.2% to 96.4%. More importantly, in-hospital mortality and major adverse cardiac events fell by approximately 50% in the intervention group compared to the control group.
What makes this study particularly valuable is what did not change. Door-to-balloon time—a traditional hospital performance metric—showed no significant difference between groups. The gains came entirely from reducing prehospital delays, not from faster in-hospital procedures. For health systems in China and globally where geographic access and public awareness remain barriers, this finding reorients the priority from hospital-centric efficiency to community-integrated readiness.
Why it matters:
For researchers and policymakers studying China’s healthcare systems, this trial provides a replicable framework for STEMI care in under-resourced regions. The lesson extends beyond cardiology: improving patient outcomes may depend less on acquiring the latest technology and more on redesigning the patient journey from symptom onset to definitive care. The model’s success in China offers a template for other middle-income countries facing similar challenges of geographic dispersion and variable hospital capability.
ScientificChina — tracking what’s happening in Chinese science, technology, research, and industrial innovation in a way global professionals can actually use.
Follow ScientificChina for deeper insight into China’s evolving science, technology, and industrial landscape.
No products in the cart.